Faeth Therapeutics, Inc. (FTH)
Market Open
17 Jul, 17:19
NASDAQ (CM) NASDAQ (CM) Primary $
25. 77
-0.17
-0.6554%
$
44.45M Market Cap
- P/E Ratio
- Div Yield
70,926 Volume
- Eps
$ 25.94
Previous Close Want to track FTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Faeth Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Kevin Roan Stempoint Capita LLP | 132,873 | $4.19M | $3.88M | -$311,587.23 | -7.44% |
| OM Olga Maltseva Catalio Capital Management LP | 14,718 | $126,280 | $429,397.65 | $303,117.65 | 240.04% |
